| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0013 | 1 |